Welcome to this edition of Brand Matters, which brings together a broad mix of developments of interest to brand owners.
Since our last edition, London has played host to the International Trademark Association Annual Meeting. We were delighted to be a Local Host firm and to welcome so many friends and connections over the course of the week – and the sun (largely!) shone.
We open this update with a landmark decision in which the High Court has extended its website blocking jurisdiction to cover websites selling counterfeit and unlicensed versions of Novo Nordisk's semaglutide and other prescription-only medicines – the first such injunction concerned with counterfeit medicinal products. For brand owners operating selective distribution systems, the Court of Appeal's decision in Deckers v Up & Running will also be welcome reading, bringing much-needed clarity to the 'by object' test under UK competition law.
This edition also has a strong AI thread. We examine the CJEU's long-awaited ruling in Pelham II on the definition of "pastiche" and explore what this might mean for AI-generated images in the style of a brand or copyright work, the UK Government's report confirming no immediate reform to copyright law in response to generative AI, and what the EU AI Act means for brand owners who affix their trade mark to an AI system developed by a third party – where the distinction between "provider" and "deployer" carries important compliance consequences.
We also bring you an update on non-traditional trade marks, and the strategic value they can offer, together with details of the challenges in registering titles of well-known books following an EUIPO Grand Board decision rejecting trade mark protection for ANIMAL FARM and 1984.
I hope you find this edition both useful and interesting. If you have any questions on the topics covered, please do drop me or any of our contributors a line.